Patents by Inventor Franco Pamparana

Franco Pamparana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS
    Publication number: 20090018193
    Abstract: The invention concerns the use of essential fatty acids with a high content in eicosapentaenoic acid ethyl ester (EPA) or docosahexaenoic acid ethyl ester (DHA) or a high concentration mixture thereof in the preparation of a medicament useful for preventing mortality, in particular due to sudden death, in patients who have suffered from a myocardial infarction.
    Type: Application
    Filed: August 15, 2008
    Publication date: January 15, 2009
    Applicant: Pfizer Italia S.R.L.
    Inventor: Franco PAMPARANA
  • ESSENTIAL N-3 FATTY ACIDS IN CARDIAC IN SUFFICIENCY AND HEART FAILURE THERAPY
    Publication number: 20090005327
    Abstract: The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), either alone or in combination with another therapeutic agent.
    Type: Application
    Filed: September 9, 2008
    Publication date: January 1, 2009
    Applicant: PFIZER ITALIA S.R.L.
    Inventors: Francesco GRANATA, Franco Pamparana, Eduardo Stragliotto
  • Essential fatty acids in the prevention of cardiovascular events
    Patent number: 7462643
    Abstract: The invention concerns the use of essential fatty acids with a high content in eicosapentaenoic acid ethyl ester (EPA) or docosahexaenoic acid ethyl ester (DHA) or a high concentration mixture thereof in the preparation of a medicament useful for preventing mortality, in particular due to sudden death, in patients who have suffered from a myocardial infarction.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: December 9, 2008
    Assignee: Pfizer Italia S.R.L.
    Inventor: Franco Pamparana
  • Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
    Patent number: 7439267
    Abstract: The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), either alone or in combination with another therapeutic agent.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: October 21, 2008
    Assignee: Pfizer Italia S.R.L.
    Inventors: Francesco Granata, Franco Pamparana, Eduardo Stragliotto
  • Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
    Publication number: 20060205814
    Abstract: The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), either alone or in combination with another therapeutic agent.
    Type: Application
    Filed: January 17, 2006
    Publication date: September 14, 2006
    Applicant: Pharmacia Italia S.P.A.
    Inventors: Francesco Granata, Franco Pamparana, Eduardo Stragliotto
  • Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
    Publication number: 20040077723
    Abstract: The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), either alone or in combination with another therapeutic agent.
    Type: Application
    Filed: November 21, 2003
    Publication date: April 22, 2004
    Inventors: Francesco Granata, Franco Pamparana, Eduardo Stragliotto